Clinical Trial Update: Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD) [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 trial assessed the effects of docosahexaenoic acid (DHA) supplementation in children with nonalcoholic fatty liver disease (NAFLD), inc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis
• Metabolic Syndrome
• Nonalcoholic Fatty Liver Disease
• Obesity

Drugs mentioned

• Docosahexaenoic acid (docosahexaenoic acid)

Snippet

Sponsor: Bambino Gesù Hospital and Research Institute | Conditions: Fatty Liver, Liver Fibrosis | Phase 1, Phase 2 | Status: COMPLETED